Literature DB >> 17611964

Pamidronate treatment of chronic noninfectious inflammatory lesions of the mandible in children.

Sandrine Compeyrot-Lacassagne1, Alan M Rosenberg, Paul Babyn, Ronald M Laxer.   

Abstract

Noninfectious inflammatory lesions of the mandible occur in chronic recurrent multifocal osteomyelitis (CRMO). Diffuse sclerosing osteomyelitis of the mandible (DSOM) is a condition thought to be a localized form of CRMO. Recently, bisphosphonate therapy, and particularly intravenous pamidronate, has been proposed as a treatment for patients with both CRMO and DSOM who do not improve with nonsteroidal antiinflammatory drug treatment. We report our experience using pamidronate in 2 children with chronic noninfectious osteomyelitis affecting the mandible. We describe the clinical and radiographic features and the treatment, side effects, and clinical and radiographic responses. Our experience suggests that pamidronate is an effective second-line therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17611964

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

1.  Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate.

Authors:  Toni Hospach; Micha Langendoerfer; Tekla von Kalle; Jan Maier; Guenther E Dannecker
Journal:  Eur J Pediatr       Date:  2010-03-27       Impact factor: 3.183

Review 2.  An Update on the Pathogenesis and Treatment of Chronic Recurrent Multifocal Osteomyelitis in Children.

Authors:  Andrea Taddio; Floriana Zennaro; Serena Pastore; Rolando Cimaz
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

3.  Case 1: Multifocal bone lesions in a teenager.

Authors:  Neha Sharma
Journal:  Paediatr Child Health       Date:  2012-03       Impact factor: 2.253

Review 4.  New discoveries in CRMO: IL-1β, the neutrophil, and the microbiome implicated in disease pathogenesis in Pstpip2-deficient mice.

Authors:  Polly J Ferguson; Ronald M Laxer
Journal:  Semin Immunopathol       Date:  2015-04-17       Impact factor: 9.623

Review 5.  Chronic recurrent multifocal osteomyelitis involving the mandible: case reports and review of the literature.

Authors:  P A J Monsour; J B Dalton
Journal:  Dentomaxillofac Radiol       Date:  2010-03       Impact factor: 2.419

Review 6.  Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis.

Authors:  Polly J Ferguson; Monica Sandu
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

Review 7.  Chronic Non-bacterial Osteomyelitis: A Review.

Authors:  Kristian Buch; Anne Cathrine Baun Thuesen; Charlotte Brøns; Peter Schwarz
Journal:  Calcif Tissue Int       Date:  2018-11-19       Impact factor: 4.333

Review 8.  Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions.

Authors:  Yongdong Zhao; Eveline Y Wu; Melissa S Oliver; Ashley M Cooper; Matthew L Basiaga; Sheetal S Vora; Tzielan C Lee; Emily Fox; Gil Amarilyo; Sara M Stern; Jeffrey A Dvergsten; Kathleen A Haines; Kelly A Rouster-Stevens; Karen B Onel; Julie Cherian; Jonathan S Hausmann; Paivi Miettunen; Tania Cellucci; Farzana Nuruzzaman; Angela Taneja; Karyl S Barron; Matthew C Hollander; Sivia K Lapidus; Suzanne C Li; Seza Ozen; Hermann Girschick; Ronald M Laxer; Fatma Dedeoglu; Christian M Hedrich; Polly J Ferguson
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-07-12       Impact factor: 4.794

9.  Update: Cytokine Dysregulation in Chronic Nonbacterial Osteomyelitis (CNO).

Authors:  Sigrun R Hofmann; Angela Roesen-Wolff; Gabriele Hahn; Christian M Hedrich
Journal:  Int J Rheumatol       Date:  2012-05-21

10.  Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO).

Authors:  Paivi Mh Miettunen; Xingchang Wei; Deepak Kaura; Walid Abou Reslan; Alberto Nettel Aguirre; James D Kellner
Journal:  Pediatr Rheumatol Online J       Date:  2009-01-12       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.